Clostridium difficle toxins as mucosal adjuvants
US5919463A · kind A · utility
34Cited by
4References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 16, 1995 |
| Grant date | Jul 6, 1999 |
| Priority date | — |
| Expiry date | Oct 16, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/825
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods and compositions for inducing protective and/or therapeutic immune responses to an antigen in a mammal. In these methods, an antigen is administered to the mammal with a toxin of a Clostridium (e.g., C. difficile), or a fragment or derivative thereof having adjuvant activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.